Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)

Truist Securities analyst Jailendra Singh reiterated a Hold rating and $23.00 price target on Hims and Hers (NYSE: HIMS)

The analyst comments "Bottom Line. HIMS shares have been volatile over the last few days, which we believe is partly attributable to the inclusion of HIMS shares into the Small-cap S&P 600 index (positive), Weight Watchers' (WW, NR) announcement of compounded semaglutide offering (mixed), and the OFA (Outsourcing Facilities Association) lawsuit against the FDA on the agency’s sudden removal of Tirzepatide (neutral). We offer our quick thoughts on the last two developments in this note."

For an analyst ratings summary and ratings history on Hims and Hers click here. For more ratings news on Hims and Hers click here.

Shares of Hims and Hers closed at $18.75 yesterday.

You May Also Be Interested In

• Stripe, Advent In Talks To Buy Paypal - WSJ
• Cantor Fitzgerald Reiterates Overweight Rating on Merlin Labs (MRLN)
• Phillips 66, Marathon Merger Talks Collapsed - Semafor